These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

907 related items for PubMed ID: 31878941

  • 21. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.
    J Exp Clin Cancer Res; 2017 May 08; 36(1):63. PubMed ID: 28482906
    [Abstract] [Full Text] [Related]

  • 22. Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumors.
    Chiu TL, Su CC.
    Mol Med Rep; 2017 May 08; 15(5):3259-3263. PubMed ID: 28339041
    [Abstract] [Full Text] [Related]

  • 23. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
    Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, Song M, Hirsch MS, Lester J, Parkash V, Karlan BY, Oren M, Hoon DS, Drapkin R.
    Cancer Res; 2019 Feb 15; 79(4):760-772. PubMed ID: 30563893
    [Abstract] [Full Text] [Related]

  • 24. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):687-696. PubMed ID: 29060967
    [Abstract] [Full Text] [Related]

  • 25. The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.
    Guo Q, Wang L, Zhu L, Lu X, Song Y, Sun J, Wu Z, Shi J, Wang Z, Zhou X.
    Gene; 2019 Sep 10; 713():143969. PubMed ID: 31299360
    [Abstract] [Full Text] [Related]

  • 26. Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
    Zhao Q, Zhong J, Bi Y, Liu Y, Liu Y, Guo J, Pan L, Tan Y, Yu X.
    Phytomedicine; 2020 Nov 10; 78():153306. PubMed ID: 32854039
    [Abstract] [Full Text] [Related]

  • 27. FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma.
    Li R, Wu H, Jiang H, Wang Q, Dou Z, Ma H, Yan S, Yuan C, Yang N, Kong B.
    Oncol Rep; 2020 Nov 10; 44(5):2143-2151. PubMed ID: 32901854
    [Abstract] [Full Text] [Related]

  • 28. 5,7,3',4'-Tetramethoxyflavone protects chondrocytes from ER stress-induced apoptosis through regulation of the IRE1α pathway.
    Wu L, Liu H, Li L, Xu D, Gao Y, Guan Y, Chen Q.
    Connect Tissue Res; 2018 Mar 10; 59(2):157-166. PubMed ID: 28436754
    [Abstract] [Full Text] [Related]

  • 29. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target.
    Wang H, Ye F, Zhou C, Cheng Q, Chen H.
    PLoS One; 2021 Mar 10; 16(2):e0245733. PubMed ID: 33635867
    [Abstract] [Full Text] [Related]

  • 30. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE, Llamosas E, Daniels B, Coopes A, Tang K, Ford CE.
    Gynecol Oncol; 2018 Mar 10; 148(3):576-584. PubMed ID: 29395309
    [Abstract] [Full Text] [Related]

  • 31. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.
    Park SH, Song JY, Kim YK, Heo JH, Kang H, Kim G, An HJ, Kim TH.
    Int J Oncol; 2014 Mar 10; 44(3):637-46. PubMed ID: 24378809
    [Abstract] [Full Text] [Related]

  • 32. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.
    Ranjan A, German N, Mikelis C, Srivenugopal K, Srivastava SK.
    Tumour Biol; 2017 Jun 10; 39(6):1010428317705517. PubMed ID: 28618969
    [Abstract] [Full Text] [Related]

  • 33. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.
    Qiu X, Klausen C, Cheng JC, Leung PC.
    Cell Death Dis; 2015 Aug 27; 6(8):e1864. PubMed ID: 26313915
    [Abstract] [Full Text] [Related]

  • 34. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.
    Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, Edelstein E, Veroslavski D, Perets R, Arbib N, Kadan Y, Fishman A, Lerer B, Ellis M, Ashur-Fabian O.
    Cancer Lett; 2021 Mar 31; 501():224-233. PubMed ID: 33221455
    [Abstract] [Full Text] [Related]

  • 35. Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.
    Kurimchak AM, Herrera-Montávez C, Brown J, Johnson KJ, Sodi V, Srivastava N, Kumar V, Deihimi S, O'Brien S, Peri S, Mantia-Smaldone GM, Jain A, Winters RM, Cai KQ, Chernoff J, Connolly DC, Duncan JS.
    Sci Signal; 2020 Feb 18; 13(619):. PubMed ID: 32071169
    [Abstract] [Full Text] [Related]

  • 36. TMBIM6 promotes diabetic tubular epithelial cell survival and albumin endocytosis by inhibiting the endoplasmic reticulum stress sensor, IRE1α.
    Xie H, Shi Y, Zhou Y, Liu H.
    Mol Biol Rep; 2022 Oct 18; 49(10):9181-9194. PubMed ID: 35857174
    [Abstract] [Full Text] [Related]

  • 37. Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
    Watson ZL, Yamamoto TM, McMellen A, Kim H, Hughes CJ, Wheeler LJ, Post MD, Behbakht K, Bitler BG.
    Clin Epigenetics; 2019 Nov 27; 11(1):165. PubMed ID: 31775874
    [Abstract] [Full Text] [Related]

  • 38. The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.
    King ER, Zu Z, Tsang YT, Deavers MT, Malpica A, Mok SC, Gershenson DM, Wong KK.
    Gynecol Oncol; 2011 Oct 27; 123(1):13-8. PubMed ID: 21726895
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
    Xiao X, Yang G, Bai P, Gui S, Nyuyen TM, Mercado-Uribe I, Yang M, Zou J, Li Q, Xiao J, Chang B, Liu G, Wang H, Liu J.
    BMC Cancer; 2016 Aug 02; 16():582. PubMed ID: 27484466
    [Abstract] [Full Text] [Related]

  • 40. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.
    Liu Z, Gersbach E, Zhang X, Xu X, Dong R, Lee P, Liu J, Kong B, Shao C, Wei JJ.
    Mol Cancer Res; 2013 Nov 02; 11(11):1314-25. PubMed ID: 24045973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.